Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Rheumatology

The Biology of MPA: Neutrophils and "Pauci-Immune" Vasculitis

At a Glance

Microscopic polyangiitis (MPA) is an autoimmune condition where MPO-ANCA antibodies overactivate white blood cells called neutrophils. These neutrophils attack small blood vessels, causing "pauci-immune" inflammation, meaning the damage occurs without large clumps of antibodies.

Understanding the biology of Microscopic Polyangiitis (MPA) helps demystify why your body is reacting this way. MPA is not an infection; it is a “misfiring” of your immune system that specifically targets the tiny plumbing of your body—the small blood vessels [1][2].

The Biological “Misfire”: ANCA and Neutrophils

In a healthy body, white blood cells called neutrophils act like first responders, rushing to the site of an infection to destroy bacteria [3]. In MPA, this process goes wrong due to ANCA (anti-neutrophil cytoplasmic antibodies) [1].

  • The Activation: About 80% of people with MPA have a specific type of antibody called MPO-ANCA [1]. These antibodies latch onto an enzyme (myeloperoxidase) inside your neutrophils, “tricking” them into thinking there is a constant, body-wide emergency [4].
  • The Trap (NETs): These “super-activated” neutrophils release Neutrophil Extracellular Traps (NETs)—webs of DNA and toxic proteins [3][5]. While NETs are meant to trap germs, in MPA they are released inside your small blood vessels, causing inflammation and damage to the vessel walls [5].

What Does “Pauci-Immune” Mean?

If you have had a kidney biopsy, you likely saw the term pauci-immune in the report. In Latin, pauci means “few” [6].

  • In many other autoimmune diseases (like lupus), the damage is caused by large “clumps” of antibodies that get stuck in the kidneys.
  • In MPA, when doctors look at the tissue under a microscope, they see severe inflammation and tissue death, but they see very few of those antibody clumps [6][7]. This tells the doctor that the damage is being done directly by the “angry” neutrophils rather than by large deposits of immune complexes [6].

MPA vs. GPA vs. EGPA: The 2022 Criteria

MPA is part of a “family” of three diseases called ANCA-associated vasculitis. In 2022, international experts (ACR/EULAR) updated the criteria to help doctors distinguish between them more accurately using a points-based system [8][9].

Feature MPA GPA EGPA
Primary ANCA MPO-ANCA (80%) [1] PR3-ANCA (frequent) [10] Variable [11]
Key Organs Kidneys, Lungs [12] Sinuses, Ears, Nose [13] Lungs, Heart, Nerves [11]
Biopsy Finding Pauci-immune [6] Granulomas (clumps) [11] Eosinophils [14]
Unique Signs No asthma [9] Sinus/Airway issues [13] Asthma, High Eosinophils [14]

Why Classification Matters

While the treatments for MPA and GPA are often very similar (using medications like Rituximab), getting the classification right helps your doctor predict which organs are most at risk for a flare (the return of active disease) [15][9]. For example, a patient with MPA is less likely to have the sinus and ear problems that are hallmark signs of GPA [13]. Regardless of the label, the goal of treatment remains the same: calming the neutrophils and protecting your organs from further damage [15].

Common questions in this guide

What does "pauci-immune" mean on a kidney biopsy?
In Latin, "pauci" means few. A pauci-immune biopsy means doctors see severe inflammation and tissue damage, but very few clumps of antibodies. This indicates the damage is being caused directly by white blood cells called neutrophils, which is a hallmark of MPA.
How do MPO-ANCA antibodies affect my body in MPA?
MPO-ANCA antibodies mistakenly latch onto an enzyme inside your neutrophils (a type of white blood cell). This tricks the neutrophils into thinking there is a body-wide emergency, causing them to release toxic webs that damage your small blood vessels.
What is the difference between MPA and GPA?
While both are types of ANCA-associated vasculitis, they affect the body differently. MPA typically involves MPO-ANCA antibodies and primarily affects the kidneys and lungs, whereas GPA often involves PR3-ANCA antibodies and frequently causes sinus, ear, and airway problems.
Why does knowing my specific type of vasculitis matter if treatments are similar?
Getting the exact classification helps your doctor predict which organs are most at risk for a future flare. For example, MPA patients are much less likely to develop the chronic sinus issues commonly seen in GPA, even though treatments for both conditions are similar.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Did my biopsy show any signs of granulomas, or was it strictly 'pauci-immune'?
  2. 2.Am I MPO-ANCA positive or PR3-ANCA positive, and how does that influence my long-term outlook?
  3. 3.How do the 2022 ACR/EULAR criteria specifically apply to my diagnosis?
  4. 4.Are we monitoring my neutrophil levels as part of my routine blood work?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Microscopic Polyangiitis: New Insights into Pathogenesis, Clinical Features and Therapy.

    Karras A

    Seminars in respiratory and critical care medicine 2018; (39(4)):459-464 doi:10.1055/s-0038-1673387.

    PMID: 30404112
  2. 2

    Treating elderly patients with ANCA-associated vasculitis.

    Jefferson JA

    Clinical journal of the American Society of Nephrology : CJASN 2015; (10(7)):1110-3 doi:10.2215/CJN.05350515.

    PMID: 26100458
  3. 3

    Neutrophil extracellular traps in neuropathy with anti-neutrophil cytoplasmic autoantibody-associated microscopic polyangiitis.

    Takeuchi H, Kawasaki T, Shigematsu K, et al.

    Clinical rheumatology 2017; (36(4)):913-917 doi:10.1007/s10067-017-3546-4.

    PMID: 28124760
  4. 4

    Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.

    Yoshida M, Yamada M, Sudo Y, et al.

    Nephrology (Carlton, Vic.) 2016; (21(7)):624-9 doi:10.1111/nep.12736.

    PMID: 26833773
  5. 5

    Presence of Citrullinated Histone H3-Positive Neutrophils in Microscopic Polyangiitis from the Early Phase: An Autopsy Proven Case.

    Matsuda Y, Hamayasu H, Seki A, et al.

    Pathology international 2016; (66(8)):466-71 doi:10.1111/pin.12434.

    PMID: 27427341
  6. 6

    Factors associated with pauci-immune glomerulonephritis in patients undergoing kidney biopsy with positive anti-neutrophil cytoplasmic antibody results.

    Lee YJ, Lee J, Ahn SM, et al.

    Journal of nephrology 2025; (38(9)):2919-2928 doi:10.1007/s40620-025-02430-2.

    PMID: 41091444
  7. 7

    The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA).

    Weiner M, Segelmark M

    Autoimmunity reviews 2016; (15(10)):978-82.

    PMID: 27481040
  8. 8

    2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis.

    Suppiah R, Robson JC, Grayson PC, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2022; (74(3)):400-406 doi:10.1002/art.41983.

    PMID: 35106973
  9. 9

    Effective Performance of the 2022 American College of Rheumatology/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Pediatric Patients: An ARChiVe Study.

    Cabral DA, Bosman ES, McPhate N, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2026; doi:10.1002/art.70172.

    PMID: 41958151
  10. 10

    Simplifying ANCA-associated vasculitis classification with ANCA specificity: a retrospective analysis.

    Zhang L, Zhang J, Xu J, et al.

    Clinical rheumatology 2025; (44(5)):1999-2008 doi:10.1007/s10067-025-07397-w.

    PMID: 40100609
  11. 11

    2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

    Chung SA, Langford CA, Maz M, et al.

    Arthritis care & research 2021; (73(8)):1088-1105 doi:10.1002/acr.24634.

    PMID: 34235880
  12. 12

    Clinical Characteristics and Outcomes of Patients With ANCA-Associated Vasculitides in a Colombian Hospital.

    Santacruz-Sandoval E, López-Bonilla J, Guevara-Calderón LA, et al.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2022; (28(2)):e491-e497 doi:10.1097/RHU.0000000000001775.

    PMID: 35192595
  13. 13

    Ocular manifestations of ANCA-associated vasculitis.

    Junek ML, Zhao L, Garner S, et al.

    Rheumatology (Oxford, England) 2023; (62(7)):2517-2524 doi:10.1093/rheumatology/keac663.

    PMID: 36440847
  14. 14

    A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis.

    Koike H, Nishi R, Yagi S, et al.

    Advances in therapy 2023; (40(1)):25-40 doi:10.1007/s12325-022-02307-x.

    PMID: 36152266
  15. 15

    Mapping a path forward: addressing disease burden, pathways and solutions in ANCA-associated vasculitis.

    Hellmich B

    Rheumatology (Oxford, England) 2026; (65(Supplement_1)):i1-i5 doi:10.1093/rheumatology/keaf517.

    PMID: 41051263

This page explains the biology and pathology of Microscopic Polyangiitis (MPA) for informational purposes only. Always consult your rheumatologist or nephrologist to interpret your specific lab results and biopsy reports.

Get notified when new evidence is published on Microscopic polyangiitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.